1. Home
  2. NABL vs PHAR Comparison

NABL vs PHAR Comparison

Compare NABL & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo N-able Inc.

NABL

N-able Inc.

HOLD

Current Price

$4.36

Market Cap

945.6M

Sector

Technology

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$14.30

Market Cap

885.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NABL
PHAR
Founded
2000
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
945.6M
885.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
NABL
PHAR
Price
$4.36
$14.30
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$8.31
$38.33
AVG Volume (30 Days)
2.4M
4.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$511,430,000.00
N/A
Revenue This Year
$11.04
$10.04
Revenue Next Year
$8.53
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
9.71
N/A
52 Week Low
$2.92
$9.54
52 Week High
$9.04
$21.34

Technical Indicators

Market Signals
Indicator
NABL
PHAR
Relative Strength Index (RSI) 69.20 58.71
Support Level $4.15 $12.98
Resistance Level $5.11 $14.81
Average True Range (ATR) 0.21 0.41
MACD 0.17 0.20
Stochastic Oscillator 94.72 67.94

Price Performance

Historical Comparison
NABL
PHAR

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: